PRO MEDICUS LIMITED — Director's Dealing 2026

Feb 15, 2026

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Deena SHIFF
Date of last notice	24 August 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [408 x 251] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest IndirectNature of indirect interest Ordinary fully paid shares in Pro Medicus(including registered holder) Limited held by Alexbel Nominees PtyNote: Provide details of the circumstances giving rise to the relevantinterest. Limited ATF Alexbel Superannuation Fund.Date of change 13 February 2026No. of securities held prior to change 1,923 ordinary shares consisting off: - 1,923 ordinary shares held under QuaInvestments ATF the Shiff GillespieFamily Trust of which the Director isa Trustee and MemberClass Ordinary sharesNumber acquired 788 ordinary sharesNumber disposed Nil----- End of picture text -----

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

==> picture [409 x 259] intentionally omitted <==

----- Start of picture text ----- Value/Consideration $126.67 per shareNote: If consideration is non-cash, provide details and estimated valuationNo. of securities held after change 2,711 ordinary shares consisting off: - 1,923 ordinary shares held under QuaInvestments ATF the Shiff GillespieFamily Trust of which the Director isa Trustee and Member 788 ordinary shares held underAlexbel Nominees PTY Limited ATFAlexbel Superannuation FundNature of change On market purchaseExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back----- End of picture text -----

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [409 x 296] intentionally omitted <==

----- Start of picture text ----- Detail of contract N/ANature of interest N/AName of registered holder N/A(if issued securities)Date of change N/ANo. and class of securities to which N/Ainterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changedInterest acquired N/AInterest disposed N/AValue/Consideration N/ANote: If consideration is non-cash, provide details and anestimated valuationInterest after change N/A----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

For and on behalf of Pro Medicus Limited

==> picture [132 x 60] intentionally omitted <==

Danny English Company Secretary 16 February 2026

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 3